Back to All Events

CBT in the Age of the DSM-5 and RDoC with Dr Stefan Hoffman

  • Weill Cornell Medical College Weill Auditorium (C-200) 445 E 69th St New York, NY, 10021 United States (map)

NYC CBT Presents: CBT in the Age of the DSM-5 and RDoC

Modern CBT refers to a family of interventions that has evolved from a specific treatment model into a mature and empirically-supported approach that incorporates a wide variety of patient-tailored treatment techniques. In this presentation, Dr. Hofmann will discuss some exciting new advancements in CBT that are an expansion of its underlying core model. Dr. Hofmann will go on to propose that these techniques and principles could serve as the framework of a new, clinically relevant nosological system.

Established professionals, early career professionals, and students from all applied, research, and academic settings are invited to attend. Tickets are non-refundable or exchangeable.

$30 for professional member ticket

$40 for professional non-member ticket

$15 for student member ticket

$20 for student non-member ticket

About Dr Stefan G. Hofman PhD

Stefan G. Hofmann, Ph.D. is Professor of Psychology at the Department of Psychology at Boston University where he directs the Psychotherapy and Emotion Research Laboratory. His main research focuses on the mechanism of treatment change, translating discoveries from neuroscience into clinical applications, emotion regulation strategies, and cultural expressions of psychopathology, such as social anxiety disorder. He has more than 200 scientific publications and 15 books. He is the immediate past president of the Association of Association for Behavior and Cognitive Therapies, president-elect of the International Association for Cognitive Psychotherapy, the editor of Cognitive Therapy and Research, Associate Editor of Journal of Consulting and Clinical Psychology.

Previous
Previous
March 27

The Dodo Bird Hypothesis & the APA Resolution of Psychotherapy Effectiveness with Dr Ray DiGiuseppe

Next
Next
October 21

On the precipice of a paradigm shift: Novel therapeutics for PTSD and Anxiety disorders. With JoAnn Difede, Ph.D.